日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis

移植前使用免疫检查点抑制剂对肝细胞癌移植后结局的影响:系统评价和个体患者数据荟萃分析

Rezaee-Zavareh, Mohammad Saeid; Yeo, Yee Hui; Wang, Tielong; Guo, Zhiyong; Tabrizian, Parissa; Ward, Stephen C; Barakat, Fatma; Hassanein, Tarek I; Dave, Shravan; Ajmera, Veeral; Bhoori, Sherrie; Mazzaferro, Vincenzo; Chascsa, David M H; Liu, Margaret C; Aby, Elizabeth S; Lake, John R; Sogbe, Miguel; Sangro, Bruno; Abdelrahim, Maen; Esmail, Abdullah; Schmiderer, Andreas; Chouik, Yasmina; Rudolph, Mark; Sohal, Davendra; Giudicelli, Heloise; Allaire, Manon; Akce, Mehmet; Guadagno, Jessica; Tow, Clara Y; Massoumi, Hatef; De Simone, Paolo; Kang, Elise; Gartrell, Robyn D; Martinez, Mercedes; Paz-Fumagalli, Ricardo; Toskich, Beau B; Tran, Nguyen H; Solino, Gabriela Azevedo; Poltronieri Pacheco, Dra Mariana; Kalman, Richard S; Agopian, Vatche G; Mehta, Neil; Parikh, Neehar D; Singal, Amit G; Yang, Ju Dong

Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis

瑞美替罗在代谢功能障碍相关脂肪肝病和脂肪性肝炎的治疗中

Jamal, Fares; Elshaer, Amani; Odeh, Nour B; Alatout, Mayar H; Shahin, Tala; Worden, Astin R; Albunni, Hashem N; Lizaola-Mayo, Blanca C; Jayasekera, Channa R; Chascsa, David M H; Vargas, Hugo E; Aqel, Bashar A

Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case report

单药免疫治疗后转移性肝细胞癌患者降期行肝移植:首例病例报告

Pirozzi, Angelo; Hoyek, Celine; Abidoye, Oluseyi; Okano, Naohiro; Nguyen, Michelle C; Byrne, Thomas; Aqel, Bashar; Chascsa, David; Alzubaidi, Sadeer; Rimassa, Lorenza; Bekaii-Saab, Tanios; Borad, Mitesh J

Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

探索代谢功能障碍相关脂肪肝病(MASLD)的多种治疗策略

Elshaer, Amani; Chascsa, David M H; Lizaola-Mayo, Blanca C

Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation

免疫检查点抑制剂作为肝移植前降低肝细胞癌分期的治疗方法

Katariya, Nitin N; Lizaola-Mayo, Blanca C; Chascsa, David M; Giorgakis, Emmanouil; Aqel, Bashar A; Moss, Adyr A; Uson Junior, Pedro Luiz Serrano; Borad, Mitesh J; Mathur, Amit K

Special Considerations in the Management of HIV and Viral Hepatitis Coinfections in Liver Transplantation

肝移植中合并HIV和病毒性肝炎感染的治疗注意事项

McCain, Josiah D; Chascsa, David M

APECED-Associated Hepatitis: Clinical, Biochemical, Histological and Treatment Data From a Large, Predominantly American Cohort

APECED相关性肝炎:来自一项以美国为主的大型队列研究的临床、生化、组织学和治疗数据

Chascsa, David M; Ferré, Elise M N; Hadjiyannis, Yannis; Alao, Hawwa; Natarajan, Mukil; Quinones, Mariam; Kleiner, David E; Simcox, Thomas L; Chitsaz, Ehsan; Rose, Stacey R; Hallgren, Asa; Kampe, Olle; Marko, Jamie; Ali, Rabab O; Auh, Sungyoung; Koh, Christopher; Belkaid, Yasmine; Lionakis, Michail S; Heller, Theo

Exogenous copper exposure causing clinical wilson disease in a patient with copper deficiency

外源性铜暴露可导致铜缺乏患者出现临床威尔逊病。

Lizaola-Mayo, Blanca C; Dickson, Rolland C; Lam-Himlin, Dora M; Chascsa, David M

Emerging therapies for PBC

原发性胆汁性胆管炎的新兴疗法

Chascsa, David Maxwell Hunter; Lindor, Keith Douglas

Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience

梅奥诊所经验:PD-1抑制剂在有肝移植史的转移性癌症患者中的初步评估

DeLeon, Thomas T; Salomao, Marcela A; Aqel, Bashar A; Sonbol, Mohamad B; Yokoda, Raquel T; Ali, Ahmad H; Moss, Adyr A; Mathur, Amit K; Chascsa, David M; Rakela, Jorge; Bryce, Alan H; Borad, Mitesh J